Middle East and Africa Percutaneous Transluminal Angioplasty Balloons Market Size, Share, Trends, And Industry Analysis: By Product Type, By Application, By End Users, and Country Forecast 2020-2031
Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons Market size was valued at US$ x million in 2024 and is expected to reach US$ x by 2031, growing at a significant CAGR of x% from 2025-2031. Percutaneous transluminal angioplasty (PTA) is a process carried to treat the peripheral artery disease (PAD) by open up the arteries that are narrowed by plaque. Rise in prevalence of coronary and peripheral artery disease, expansion of the business by companies in Middle East region, development in healthcare infrastructure, and rise in awareness about the PTA balloons in South Africa are expected to propel the Middle East and Africa percutaneous transluminal angioplasty balloons market over the forecast period. However, stringent guidelines for product approval, high cost of PTA balloons, lack of awareness about advanced products in underdeveloped countries, and alternative treatment for peripheral and coronary artery disease may hamper the Middle East and Africa percutaneous transluminal angioplasty balloons market.
The number of cooperation and tie-ups between major players is increasing. For example, QT Vascular (Singapore) inked a final agreement with Medtronic in February 2017 for the Middle East and Africa distribution of its Chocolate percutaneous transluminal angioplasty (PTA) catheter for five years, with two one-year extensions automatically renewed. RESTRAINTS : Recalls of products. After receiving multiple reports of balloons bursting below the device's rated burst pressure, Cook recalled three types of a balloon catheter used for leg angioplasty treatments in June 2019.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
By Product Type |
|
|
By Application |
|
|
By End User |
|
|
By Country |
|
Download Free Sample Report
The Middle East and Africa percutaneous transluminal angioplasty (pta) balloons market size was valued at US$ x million in 2024 and is expected to reach US$ x by 2031, growing at a significant CAGR of x% from 2025-2031.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1.Executive Summary |
| 2. Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons Market Introduction |
| 2.1. Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons Market - Taxonomy |
| 2.2. Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 3. Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Drug-Eluting Balloons |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Normal Balloons |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Scoring Balloons |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Cutting Balloons |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Peripheral Artery Disease |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Coronary Artery Disease |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Cardiology Clinics |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Ambulatory Surgical Centers |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Competition Landscape |
| 8.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 8.2.1.R. Bard, Inc. (U.S.) |
| 8.2.2.Cook Medical, Inc. (U.S.) |
| 8.2.3.Abbott, Inc. (U.S.) |
| 8.2.4.Cardinal Health, Inc. (U.S.) |
| 8.2.5.Boston Scientific Corporation (U.S.) |
| 8.2.6.Medtronic Plc (Ireland) |
| 9. Research Methodology |
| 10. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
